Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119417) titled 'Mechanism of Upregulation of Piezo1-TRPV4 Mediating the Enhancement of Pulmonary Mechanical Sensitivity after Neoadjuvant Chemotherapy by the NETs-IL-18-IL-1ß-NLRP3 Axis' on Feb. 26.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Jiangsu Province Hospital
Condition:
Chemotherapy-related lung injury
Intervention:
Neoadjuvant chemotherapy group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-09
Target Sample Size: Neoadjuvant chemotherapy group:20; No chemotherapy group:20;
Countries of Recruitment:
China
To know more, visit https...